OverviewChartNewsTraderScreen

BVT Bonus Zert AMD 27.09.2024/  DE000VD20KM7  /

Frankfurt Zert./VONT
2024-05-22  1:54:06 PM Chg.+2.020 Bid2:38:28 PM Ask2:38:28 PM Underlying Strike price Expiration date Option type
176.930EUR +1.15% 177.110
Bid Size: 2,400		 177.350
Ask Size: 2,400		 Advanced Micro Devic... - USD 2024-09-27 Call
GlobeNewswire 05-21 AMD Instinct MI300X Accelerators Power Microsoft Azure OpenAI Service Workloads and New Azure ND MI3...
GlobeNewswire 05-21 AMD Expands EPYC CPU Portfolio to Bring New Levels of Performance and Value for Small and Medium Bus...
GlobeNewswire 05-21 Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroi...
GlobeNewswire 05-21 YieldMax™ Launches Option Income Strategy ETF on the VanEck® Gold Miners ETF (GDX®)
TeleTrader 05-20 Microsoft will 'soon welcome' AMD, Intel chips
GlobeNewswire 05-20 Broadcom Revolutionizes AI Networking Landscape with High-Performance 400G RoCE/RDMA Ethernet NICs
Newsfile Corp 05-16 FDA Grants AI-Powered Notal Vision Home OCT "SCANLY" De Novo Marketing Authorization
GlobeNewswire 05-15 Outlook Therapeutics® Reports Financial Results for Second Quarter Fiscal Year 2024 and Provides Cor...
GlobeNewswire 05-14 AMD Announces Upcoming Events for the Financial Community
GlobeNewswire 05-14 Apellis Pharmaceuticals Refinances Existing Debt with Up to $475 Million Non-Dilutive Credit Facilit...
GlobeNewswire 05-14 Belite Bio Reports First-Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 05-13 Outlook Therapeutics® Announces UK Submission of Marketing Authorization Application (MAA) for ONS-5...
GlobeNewswire 05-13 AMD Remains the Partner of Choice for World’s Fastest and Most Efficient High Performance Computing ...
GlobeNewswire 05-09 Clearside Biomedical Announces First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 05-09 Adverum Biotechnologies Reports First Quarter 2024 Financial Results and Provides Pipeline Highlight...
GlobeNewswire 05-09 4DMT Reports First Quarter 2024 Financial Results and Operational Highlights
GlobeNewswire 05-08 Alkeus Pharmaceuticals Announces Positive Interim Results Demonstrating No Signs of Disease Progress...
GlobeNewswire 05-08 Therini Bio Announces Positive Preclinical Data Supporting the Development of THN391 in Neurodegener...
GlobeNewswire 05-08 AMD Receives IEEE 2024 Corporate Innovation Award for Leadership in Chiplet Design for High-Performa...
GlobeNewswire 05-08 Belite Bio to Host Webcast on May 14, 2024, to Discuss First Quarter 2024 Financial Results
GlobeNewswire 05-08 EyePoint Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Corporat...
GlobeNewswire 05-07 Ocular Therapeutix™ Reports First Quarter 2024 Results
GlobeNewswire 05-07 Optiver Chooses AMD Enterprise Portfolio to Power its Data Center Modernization, Enabling New Era of...
GlobeNewswire 05-07 Apellis Pharmaceuticals Reports First Quarter 2024 Financial Results
GlobeNewswire 05-07 Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)